Neuberg ProLife plans 10 Integrated Diagnostics and Wellness Centres and more than 100 satellite laboratories and sample collection centres across Odisha within two years.
Bhubaneswar, 24 September 2026: Neuberg Diagnostics, one of India’s leading integrated diagnostic networks, has entered into a strategic joint venture with Bhubaneswar-based ProLife Diagnostics to expand access to high-quality, affordable and advanced diagnostic services across Odisha.
The new venture, Neuberg ProLife, will combine Neuberg’s pan-India scale, advanced diagnostic capabilities, high-end technology, AI-enabled IT platforms and quality systems with ProLife’s established reputation, local presence and deep understanding of Odisha’s healthcare ecosystem. Neuberg ProLife will offer a comprehensive portfolio spanning routine and specialised pathology, radiology, preventive wellness and advanced diagnostics, including genomics, metabolomics, proteomics, digital pathology and AI-enabled advanced radiology.
Dr. GSK Velu, Chairman and Managing Director, Neuberg Diagnostics said “Odisha is an important market in Neuberg’s pan-India expansion journey, with significant potential to improve access to quality and advanced diagnostics beyond the major urban centres. Through Neuberg ProLife, we are bringing together Neuberg’s technology, advanced diagnostic expertise and national scale with ProLife’s strong local presence and understanding of Odisha. Our vision is to build a future-ready diagnostic network focused on accessibility, affordability, early detection and preventive healthcare.”
As part of its expansion strategy, Neuberg ProLife plans to establish 10 Integrated Diagnostics and Wellness Centres across Bhubaneswar, Cuttack, Rourkela, Berhampur, Sambalpur, Puri, Balasore, Bhadrak, Baripada and Jharsuguda. These centres will be supported by more than 100 satellite laboratories and sample collection centres across Odisha within the next two years. The hub-and-spoke network will enable patients across Tier 2, Tier 3 and emerging markets to access routine and specialised diagnostic services closer to home, reducing the need to travel to larger cities for advanced investigations.
Ms. Sunaina Bihani, CEO and Managing Director, Neuberg Pulse Diagnostics said “Odisha, a land of rich heritage and spirituality, is emerging as a promising growth market. As the state progresses, access to quality healthcare will become increasingly important. Our partnership with ProLife combines Neuberg’s technology and specialised diagnostic capabilities with ProLife’s strong local presence and trust. Together, we aim to expand access to advanced, affordable diagnostics and deliver consistent quality and a better patient experience across Odisha.”
Dr. Manas Baisakh, CEO & Director, ProLife Diagnostics and nationally renowned pathologist said, “Diagnostics is rapidly evolving from detecting disease after symptoms appear to identifying risks earlier and enabling preventive and personalised healthcare. Neuberg ProLife will bring these capabilities closer to patients and clinicians across Odisha, with accuracy, quality and timely reporting at its core.”
Dr Satyasundar Mohapatra, Director, Prolife Diagnostics and a nationally renowned radiologist said, “Through this strategic partnership, Neuberg ProLife aims to build a strong state-wide diagnostics platform that combines local trust and accessibility with national expertise, advanced technology and uncompromising quality, making routine, preventive and advanced diagnostics more accessible and affordable across Odisha.”
Wodehouse Capital Advisors were the exclusive advisors to this Transaction. Mihir Kapadia, Director – Wodehouse Capital mentioned “Odisha presents a significant opportunity to expand access to quality diagnostics. We are delighted to have advised on this prestigious transaction, which will strengthen advanced diagnostic capabilities across the state and create meaningful value for healthcare in Odisha.”
About Neuberg Diagnostics:Neuberg Diagnostics, headquartered in Chennai, is one of India’s leading diagnostic service providers, with a presence across India, the UAE, South Africa and the USA. With over 200 CAP and NABL-accredited laboratories, Neuberg has emerged as one of the fastest-growing and trusted diagnostic networks in the country. The group offers access to state-of-the-art integrated diagnostic technologies and is supported by a team of experienced clinical pathologists, biochemists, geneticists, radiologists and other certified healthcare professionals. With the capability to perform over 6,000 varieties of pathological and radiological investigations and process 30 million tests annually, Neuberg is advancing newer-generation diagnostic techniques in the field of personalised medicine across 250+ cities globally. The organisation aims to make accurate and affordable diagnostics accessible across communities, supported by home collection services reaching over 5,500 pin codes.
